ImageneBio, Inc. (IMA) — Institutional Holders, Q2 2026
36 institutional investment managers reported a IMA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $37.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
IMA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- ORBIMED ADVISORSAdded · +530,713 sh+$3.1M
- Trails Edge Capital PartnersNew · +282,004 sh+$1.7M
- Monashee Investment ManagementNew · +192,344 sh+$1.1M
- Stonepine Capital ManagementNew · +96,172 sh+$567.4K
- Cable Car CapitalAdded · +26,850 sh+$158.4K
Biggest sellers
- CITADEL ADVISORSTrimmed · -68,735 sh-$405.5K
- Blue Owl CapitalTrimmed · -41,645 sh-$245.7K
- JACOBS LEVY EQUITY MANAGEMENTSold out · -26,663 sh-$157.3K
- XTX Topco LtdSold out · -15,112 sh-$89.2K
- HRT FINANCIALSold out · -13,909 sh-$82.1K
IMA 13F holders ranked 1–36 of 36
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | BVF#1 · 1,110,002 sh | 1,110,002 | $6.5M | 0.17% | 0.0% |
| 2 | Blue Owl Capital#2 · 917,692 sh | 917,692 | $5.4M | 0.81% | -4.3% |
| 3 | ORBIMED ADVISORS#3 · 909,269 sh | 909,269 | $5.4M | 0.10% | +140.2% |
| 4 | Cable Car Capital#4 · 781,599 sh | 781,599 | $4.6M | 0.10% | +3.6% |
| 5 | Omega Fund Management#5 · 455,361 sh | 455,361 | $2.7M | 1.45% | 0.0% |
| 6 | RTW INVESTMENTS#6 · 334,445 sh | 334,445 | $2.0M | 0.02% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT#7 · 320,518 sh | 320,518 | $1.9M | 0.00% | -1.4% |
| 8 | Trails Edge Capital Partners#8 · 282,004 sh | 282,004 | $1.7M | 0.26% | New |
| 9 | BML Capital Management#9 · 200,730 sh | 200,730 | $1.2M | 0.67% | 0.0% |
| 10 | Monashee Investment Management#10 · 192,344 sh | 192,344 | $1.1M | 1.90% | New |
| 11 | BlackRock#11 · 135,090 sh | 135,090 | $797.0K | 0.00% | +4.5% |
| 12 | Stonepine Capital Management#12 · 96,172 sh | 96,172 | $539.0K | 0.25% | New |
| 13 | RENAISSANCE TECHNOLOGIES#13 · 86,930 sh | 86,930 | $512.9K | <0.01% | +6.4% |
| 14 | ADAGE CAPITAL PARTNERS GP, L.L.C.#14 · 66,666 sh | 66,666 | $393.3K | <0.01% | 0.0% |
| 15 | CITADEL ADVISORS#15 · 55,610 sh | 55,610 | $328.1K | 0.00% | -55.3% |
| 16 | GEODE CAPITAL MANAGEMENT#16 · 53,512 sh | 53,512 | $315.8K | 0.00% | -10.7% |
| 17 | NEA Management Company#17 · 50,005 sh | 50,005 | $295.0K | 0.02% | 0.0% |
| 18 | NANO CAP NEW MILLENNIUM GROWTH FUND L P#18 · 50,000 sh | 50,000 | $295.0K | 0.23% | +66.7% |
| 19 | HSBC PLC#19 · 34,228 sh | 34,228 | $208.4K | <0.01% | -1.9% |
| 20 | Sofinnova Ventures#20 · 31,884 sh | 31,884 | $188.1K | <0.01% | 0.0% |
| 21 | VANGUARD FIDUCIARY#21 · 27,475 sh | 27,475 | $162.1K | 0.00% | +0.7% |
| 22 | Rangeley Capital#22 · 20,090 sh | 20,090 | $118.5K | 0.11% | -38.4% |
| 23 | TWO SIGMA INVESTMENTS#23 · 19,900 sh | 19,900 | $117.4K | <0.01% | New |
| 24 | Aldebaran Capital#24 · 18,124 sh | 18,124 | $106.9K | 0.08% | -2.4% |
| 25 | Shay Capital#25 · 18,080 sh | 18,080 | $106.7K | <0.01% | -5.5% |
| 26 | MORGAN STANLEY#26 · 16,678 sh | 16,678 | $98.4K | 0.00% | -9.1% |
| 27 | GOLDMAN SACHS GROUP#27 · 15,485 sh | 15,485 | $91.4K | 0.00% | +35.1% |
| 28 | NORTHERN#28 · 11,271 sh | 11,271 | $66.5K | 0.00% | New |
| 29 | BARCLAYS PLC#29 · 10,797 sh | 10,797 | $63.7K | 0.00% | -1.5% |
| 30 | UBS Group AG#30 · 6,879 sh | 6,879 | $40.6K | 0.00% | +26.7% |
| 31 | Tower Research Capital (TRC)#31 · 675 sh | 675 | $4.0K | <0.01% | -33.2% |
| 32 | Vanguard Global Advisers#32 · 602 sh | 602 | $3.6K | 0.00% | 0.0% |
| 33 | Caitong International Asset Management , Ltd#33 · 464 sh | 464 | $2.7K | <0.01% | New |
| 34 | NewEdge Advisors#34 · 160 sh | 160 | $944.00 | 0.00% | New |
| 35 | JPMORGAN CHASE#35 · 70 sh | 70 | $425.00 | 0.00% | -76.1% |
| 36 | BNP PARIBAS FINANCIAL MARKETS#36 · 24 sh | 24 | $142.00 | 0.00% | 0.0% |
Funds that sold out of IMA in Q2 2026 (8)
Held IMA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT26,663 sh | 26,663 | $133.3K |
| XTX Topco Ltd15,112 sh | 15,112 | $75.6K |
| HRT FINANCIAL13,909 sh | 13,909 | $69.0K |
| JANE STREET GROUP13,210 sh | 13,210 | $66.0K |
| PRELUDE CAPITAL MANAGEMENT12,990 sh | 12,990 | $65.0K |
| ROYAL BANK OF CANADA1,000 sh | 1,000 | $5.0K |
| CITIGROUP224 sh | 224 | $1.1K |
| WELLS FARGO & COMPANY41 sh | 41 | $205.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.